Dapsone structure discovered in the early twentieth century, German researcher Paul Ehrlich was acquiring notions of selective toxicity established fundamentally on the ability of specific dyes to destroy microorganisms. Gerhard Domagk was later awarded a Nobel Prize for his efforts, achieving a breakthrough in 1932 with the discovery of the antiseptic ingredient Prontosil inflamed (actinodin sulfonamide). Further inquiry of the chemical factors involved opened the technique for sulfa structures and sulfone rehabilitation, beginning with the sighting of sulfanilamide, the active mediator of Prontosil, with Daniel Bovet and his team at the Pasteur Institute (1935), followed by the discovery of dapsone independently by Ernest Fourneau in France and Gladwin Buttle in the United Kingdom. Sulfonamides act as affordable inhibitors of the enzyme dihydropteroate synthetase and reduce the creation of tetrahydrofolate in bacterial cells. Tetrahydrofolate is important in both human and bacterial cells as an enzyme coenzyme that provides one-carbon units for the synthesis of pyrimidines, which are essential for DNA synthesis. If DNA and pyrimidine synthesis are inhibited, the cell cannot grow and divide. The discovery of the chemical structure of sulfa drugs had a great impact on the development of pharmaceutical sciences, photo-biochemistry, especially in the field of skin ointments used to treat skin rashes, eczema, psoriasis, and other purulent inflammatory diseases. Medicinal corporations construct SO₂ and DAP through accurate photo-industrial practices, confirming soaring excellence and integrity. These APIs exist then used in the formulation of different antibiotic products, like tablets, capsules, and suspensions, which are recommended by health care specialists to treat bacterial diseases. Overall, sulfonamides, and DAP are considered biological substances that play a fundamental responsibility in preventing bacterial toxins, supporting affected patients with actual and directed antibiotic behaviors today.

1. Florian R, Tom L, Petrick E. Exploring the supramolecular interactions and thermal stability of dapsone:Bipyridine cocrystals by combining computational chemistry with experimentation. Cryst Growth Des. 2023;23(6):4638–4654. 2. Guo C, Zhang Q, Zhu B, Zhang Z, Ma X, Dai W, et al. Drug–drug cocrystals provide significant improvements of drug properties in treatment with progesterone. Cryst Growth Des. 2020;20(5):3053–3063. 3. Bianfei X, Singa W, Yanjie Z, Jingwen W, Henry H, Chenguang W, et al. Extended release of highly water soluble isoniazid attained through cocrystallization with curcumin. Cryst Growth Des. 2020;20(3):1951–1960. 4. Altagracia M, Monroy-Noyola A, Osorio-Rico L, Kravzov J, Varado-Calvillo R, Manjarrez-Marmolejo J, et al. Dapsone attenuates kainic acid-induced seizures in rats. Neurosci Lett. 1994;176(3):52–54. 5. Anderson R, Gatner EM, van Rensburg CE, Grabow G, Imkamp FM, Kok SK, et al. In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy. Antimicrob Agents Chemother. 1981;19(8):495–503. 6. Anderson R. Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro. Antimicrob Agents Chemother. 1985;27(12):257–362. 7. Ashurst JV, Wasson MN, Hauger W, Fritz WT. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. J Am Osteopath Assoc. 2010;110(3):16–20. 8. Deng A, Zhang Y, Huang Y, Zhang M, Lou B. Preparation, crystal structures, and oral bioavailability of two cocrystals of emodin with berberine chloride. Cryst Growth Des. 2018;18(12):7481–7488. 9. Beiguelman B, Pisam RC. Effect of DDS on phytohemagglutinin-induced lymphocyte transformation. Int J Lepr Other Mycobact Dis. 1974;42:412–415. 10. Berlow BA, Liebhaber MI, Dyer Z, Spiegel TM. The effect of dapsone in steroid-dependent asthma. J Allergy Clin Immunol. 1991;87:710–715. 11. Bernstein JE, Lorincz AL. Sulfonamides and sulfones in dermatologic therapy. Int J Dermatol. 1981;20:81–88. 12. Bissinger EM, Heinke R, Spannhoff A, Eberlin A, Metzger E, Cura V, et al. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorg Med Chem. 2011;29:3717–3731. 13. Blasum C. Untersuchung zur beinflussung der interleukin-8-spiegel in lipopolysaccharid-stimulierten vollblut gesunder probanden durch in der dermatologie angewandte antiinflammatorische pharmaka mit antioxidativer potenz [thesis]. Dresden: Technical University, University Hospital, Department of Dermatology; 1998. 14. Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy. 1999;54:765–766. 15. Bonney RJ, Wightman PD, Dahlgren ME, Sadowski SJ, Davies P, Jensen N, et al. Inhibition of the release of prostaglandins, leukotrienes and lysosomal acid hydrolases from macrophages by selective inhibitors of lecithin biosynthesis. Biochem Pharmacol. 1983;32:361–366. 16. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992;98:135–140. 17. Mahmood N. The various preparation methods in synthetic chemistry. 1st ed. Evincepub Publishing House; 2019. 18. Novikov EM, Castañeda R, Fonari MS, Timofeeva TV. A 1:1 flavone cocrystal with cyclic trimeric perfluoro-o-phenylenemercury. Acta Crystallogr E Crystallogr Commun. 2024;80(7):717–720. 19. Mahmood N. Reactions and mechanisms. 1st ed. IJMRA Publication; 2018. 20. Matheus ME, de Almeida Violante F, Garden SJ. Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line. Eur J Pharmacol. 2007;556:200–206. 21. Perro A, Reculusa S, Bourgeat-Lami E, Duguet E, Ravaine S. Synthesis of hybrid colloidal particles: From snowman-like to raspberry-like morphologies. Colloids Surf A Physicochem Eng Asp. 2006;284:78–83. 22. Mahmood N. Synthesis and biological study of hetero (atoms and cycles) compounds. Der Pharma Chemica. 2016;8(6):40–48. 23. Pera-Titus M, Leclercq L, Clacens JM, De Campo F, Nardello-Rataj V. Pickering interfacial catalysis for biphasic systems: From emulsion design to green reactions. Angew Chem Int Ed. 2015;54(7):2006–2021. 24. Mahmood N. Survey on methods of preparation and cyclization of heterocycles. Int J Chem Mol Eng. 2020;6(2):19–36. 25. Fan Z, Tay A, Pera-Titus M, Zhou WJ, Benhabbari S, Feng X. Pickering interfacial catalysts for solvent-free biomass transformation: Physicochemical behavior of non-aqueous emulsions. J Colloid Interface Sci. 2014;427:80–90. 26. Casagrande C, Fabre P, Raphael E, Veyssie M. Janus beads: Realization and behavior at water oil interfaces. Europhys Lett. 1989;9(3):251–255. 27. Mahmood N. Synthesis and chemical identification of macro compounds of (thiazol and imidazol). Res J Pharm Tech. 2015;8(1):78–84. 28. Yang L, Yue J, Zhou B, Zheng S. Purification, characterization and study of blue fluorescent substance in caffeine. J Chem Technol Biotechnol. 2024;99(5):1225–1239. 29. Mahmood N. The various preparation methods in synthetic chemistry. 2019. 30. Nagham MA. Synthesis of antifungal chemical compounds from fluconazole with (pharma-chemical) studying. Res J Pharm Biol Chem Sci. 2017;8(3):564–573. 31. Mehta SL, Manhas N, Raghubiz R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007;54:34–66. 32. Mahmood N. Review on (azo, formazane, sulfazane)-compounds. Int J Innov Sci Eng. 2019;10:19–45. 33. Faria J, Ruiz MP, Resasco DE. Phase-selective catalysis in emulsions stabilized by Janus silica-nanoparticles. Adv Synth Catal. 2010;352(14–15):2359–2364. 34. Naumann d’Alnoncourt R, Csepei LI, Hävecker M, Girgsdies F, Schuster ME, Schlögl R, et al. The reaction network in propane oxidation over phase-pure MoVTeNb M1 oxide catalysts. J Catal. 2014;311:369–385. 35. Mahmood N. Experimental methods for preparation of Mannich bases, formazan, normal and cyclic sulfur compounds. 1st ed. Evince Pub Publishing House; 2018. 36. Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA. Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes. J Am Acad Dermatol. 2018;79(4):617–633. 37. Liang SE, Hoffmann R, Peterson E, Soter NA. Use of dapsone in the treatment of chronic idiopathic and autoimmune urticaria. JAMA Dermatol. 2019;155(1):90–95. 38. Mahmood N. Alternative methods in organic synthesis. 1st ed. Eliva Press SRL; 2020. 39. Mokrani T, van Reenen A, Amer I. Molecular weight and tacticity effect on morphological and mechanical properties of Ziegler–Natta catalyzed isotactic polypropylenes. Polimeros. 2015;25(6):556–563. 40. Mahmood N. Survey on methods of preparation and cyclization of heterocycles. Int J Chem Mol Eng. 2020;6(2):10–27. 41. Rasool SR, Mahmood N, Al-Zuhairi AJ. Guanine substituted heterocyclic derivatives as bioactive compounds. Biochem Cell Arch. 2020;20(Suppl 2):3651–3655. 42. Wasaf AAK. Studying of thermal, spectral and liquid crystal properties of new monomers for Schiff base reaction. Al-Harf J. 2024;(20). 43. Dub PA, Gordon JC. The role of the metal-bound N–H functionality in Noyori-type molecular catalysts. Nat Rev Chem. 2018;2(12):396–408.